Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Baser

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Pain Medicine (Malden, Mass.)|June 17, 2014
Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patientsBarbara Zedler, Lin Xie, Li Wang, et al.
Vaccines|June 25, 2026
Administration Timing of Respiratory Syncytial Virus Preventatives Among Commercially Insured Populations in the United States: 2024-2025 RSV SeasonAmy W Law, Danielle C Mayer, Marjan Zakeri, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of CareW Frank Peacock, Craig I Coleman, Phil Wells, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Clinical Therapeutics|June 28, 2017
Overall Effectiveness of Rivaroxaban in Patients with Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Market Access & Health Policy|November 26, 2025
The Impact of Copay Accumulators and Maximizers on Treatment Patterns, Adherence, and Costs Among Patients with Major Depressive and Bipolar Disorders Treated with Branded TherapiesOnur Baser, Katarzyna Rodchenko, Heidi C Waters, et al.
Plos One|October 11, 2017
Benefit of early discharge among patients with low-risk pulmonary embolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Thrombosis and Thrombolysis|February 8, 2019
The value of sPESI for risk stratification in patients with pulmonary embolismPhil Wells, W Frank Peacock, Gregory J Fermann, et al.
International Journal of Colorectal Disease|April 17, 2018
Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancerBenjamin A Kuritzkes, Emmanouil P Pappou, Ravi P Kiran, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Pain Medicine (Malden, Mass.)|June 17, 2014
Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patientsBarbara Zedler, Lin Xie, Li Wang, et al.
Vaccines|June 25, 2026
Administration Timing of Respiratory Syncytial Virus Preventatives Among Commercially Insured Populations in the United States: 2024-2025 RSV SeasonAmy W Law, Danielle C Mayer, Marjan Zakeri, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of CareW Frank Peacock, Craig I Coleman, Phil Wells, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Clinical Therapeutics|June 28, 2017
Overall Effectiveness of Rivaroxaban in Patients with Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Market Access & Health Policy|November 26, 2025
The Impact of Copay Accumulators and Maximizers on Treatment Patterns, Adherence, and Costs Among Patients with Major Depressive and Bipolar Disorders Treated with Branded TherapiesOnur Baser, Katarzyna Rodchenko, Heidi C Waters, et al.
Plos One|October 11, 2017
Benefit of early discharge among patients with low-risk pulmonary embolismLi Wang, Onur Baser, Phil Wells, et al.
Journal of Thrombosis and Thrombolysis|February 8, 2019
The value of sPESI for risk stratification in patients with pulmonary embolismPhil Wells, W Frank Peacock, Gregory J Fermann, et al.
International Journal of Colorectal Disease|April 17, 2018
Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancerBenjamin A Kuritzkes, Emmanouil P Pappou, Ravi P Kiran, et al.
Pageof 16